Yes, you may carry indomethacin when traveling, but keep the medication in its original packaging with a pharmacist-signed label that shows your name, the drug name, dosage, and prescribing clinician. Check the destination country's regulations, as some nations may have restrictions on NSAID quantities.
Indomethacin tablets are typically round, film-coated, and may be white, yellow, or orange depending on the manufacturer and strength (e.g., 25 mg tablets often have a different imprint from 50 mg tablets). The imprint code is printed on one side and helps identify the specific product.
Indomethacin is not a performance-enhancing substance and is not listed on the World Anti-Doping Agency (WADA) prohibited list. However, athletes should disclose any medication use to their governing body, as some anti-doping agencies may request a therapeutic use exemption (TUE) for certain NSAIDs.
Both are NSAIDs, but indomethacin generally provides a more potent anti-inflammatory effect at comparable doses, making it a preferred first-line oral agent for acute gout flares. Ibuprofen may be used when indomethacin is contraindicated or not tolerated.
Patients with stable, mild cardiovascular disease may use indomethacin, but the drug can increase blood pressure and cardiovascular risk. It is essential to monitor blood pressure regularly and discuss alternatives with a cardiologist if you have a heart condition.
Take the missed tablet as soon as you remember unless it is almost time for your next scheduled dose. In that case, skip the missed dose and continue with your regular dosing schedule. Do not double the dose.
Taking indomethacin with food or a full glass of milk slows gastric irritation without significantly affecting overall absorption. It is recommended to ingest the medication with a meal or snack to minimise gastrointestinal side effects.
Yes, indomethacin is available as a generic medication produced by several licensed UK pharmaceutical companies. Generic tablets contain the same active ingredient and are bioequivalent to branded formulations.
Because of its higher risk of gastrointestinal, renal, and cardiovascular adverse effects, clinicians often limit indomethacin to the shortest effective duration-typically a few days for acute gout or a brief trial for severe inflammatory arthritis-to balance benefit and safety.
Indomethacin belongs to the pain-relief therapeutic class and is an non-steroidal anti-inflammatory drug (NSAID). It is supplied as an oral pill in strengths of 25 mg, 50 mg and 75 mg. In the United Kingdom, indomethacin is a prescription-only medicine (Rx) regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). It is marketed by several manufacturers under the generic name indomethacin, and various brand names may appear on the packaging.
Indomethacin blocks the activity of cyclo-oxygenase (COX-1 and COX-2) enzymes, which are essential for the production of prostaglandins-lipid compounds that promote inflammation, pain, and fever. By reducing prostaglandin synthesis, indomethacin:
The drug is rapidly absorbed from the gastrointestinal tract, reaching peak plasma concentrations within 1-2 hours. Its half-life is approximately 4-5 hours, and it is metabolised mainly in the liver before being excreted by the kidneys.
Indomethacin is approved by the MHRA for the following adult indications:
It is generally prescribed when a potent anti-inflammatory effect is needed and other NSAIDs are insufficient.
Disclaimer: Off-label use of indomethacin requires careful medical supervision, individualized risk assessment, and informed consent.
Absolute contraindications
Relative contraindications
Special populations
Major interactions
Warfarin - increased anticoagulant effect, ↑ risk of bleeding
Other NSAIDs or corticosteroids - additive GI toxicity
ACE inhibitors / ARBs - potential reduction in renal perfusion, especially in volume-depleted patients
Lithium - indomethacin can raise serum lithium levels, risking toxicity
Methotrexate - reduced clearance, ↑ risk of myelosuppression
Moderate interactions
Selective serotonin reuptake inhibitors (SSRIs) - modestly increased bleeding risk
Diuretics (e.g., furosemide) - may enhance nephrotoxic potential
Standard dosing (adults)
Acute gout flare: 50 mg three times daily; may be increased to 75 mg three times daily based on response, not exceeding 225 mg per day.
Rheumatoid arthritis / ankylosing spondylitis: 25 mg to 50 mg three times daily, adjusted to the lowest effective dose.
Renal or hepatic impairment - Start with the lowest dose (25 mg) and increase only if necessary, with close monitoring of kidney and liver function.
Administration - Swallow tablets whole; do not crush or chew. If difficulty swallowing, the tablet may be taken with a small amount of applesauce, provided the entire dose is consumed promptly.
Missed dose - Take the missed tablet as soon as remembered unless it is near the time of the next scheduled dose; do not double up.
Overdose - Symptoms may include severe nausea, vomiting, abdominal pain, dizziness, or renal failure. Seek emergency medical care; supportive measures and activated charcoal may be employed.
Discontinuation - For long-term therapy, gradual dose reduction is recommended to avoid rebound inflammation, especially in chronic arthritic conditions.
This article provides educational information about indomethacin and is not a substitute for professional medical advice. Treatment decisions, including the use of indomethacin for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
